Is Litigation Funding Legal? Regulation in the US, UK and EU Compared

Ask a lawyer in Ohio, one in London, and one in Frankfurt whether litigation funding is legal, and you’ll get three genuinely different answers, none of them wrong. That’s the reality compliance teams are dealing with right now. The answer depends entirely on where the case sits, which court hears it, and which regulatory reform happens to be sitting in a legislature at the moment you ask. Here’s the actual state of play across the US, UK, and EU as of mid-2026, without the usual hand-waving.

Why This Question Isn’t a Single Yes or No Answer

Different Jurisdictions, Different Starting Assumptions

Here’s the thing that trips up a lot of in-house counsel doing cross-border work: third party litigation funding isn’t governed by one unified rulebook anywhere in the world. It sits at the intersection of contract law, civil procedure, consumer protection, and legal ethics, and each jurisdiction inherited its own starting assumptions. Some places treat it the way they’d treat any commercial contract. Others still carry old doctrines around champerty and maintenance that technically restrict outside parties from funding someone else’s lawsuit, even where those doctrines are rarely enforced anymore.

Think of it like international shipping regulations. The cargo is the same, but the rules at each port differ enough that experienced operators build separate compliance playbooks for each stop. That’s exactly what litigation funding regulation looks like right now for anyone operating across the US, UK, and EU simultaneously.

The United States: A Patchwork of State Rules and a Federal Disclosure Fight

State-Level Rules and Interest Rate Caps

There’s no single federal law answering whether third party litigation funding is legal in the US. Instead, individual states set their own rules, some through statute, some through case law, and a few, like Nebraska and Louisiana, through licensing regimes specifically built for litigation funders. Several states also cap the effective return a funder can charge, treating consumer-facing funding agreements a bit like short-term lending products subject to usury-style limits.

The Push for Federal Disclosure

What’s shifted meaningfully in 2026 is the federal conversation. Multiple bills are moving through Congress aimed at forcing disclosure of funding arrangements in federal litigation. The Litigation Funding Transparency Act of 2026, introduced by Senator Chuck Grassley, would require parties to name any outside funder involved in a covered civil action, with particular attention to class actions, multidistrict litigation, and large coordinated proceedings. A good chunk of what’s driving this bill is growing congressional unease about foreign sovereign entities and foreign-controlled companies quietly bankrolling US lawsuits.

Separately, industry groups have pushed the Federal Civil Rules Advisory Committee to amend Rule 26 itself. That proposal would require parties to identify any nonparty funder with a financial interest in the litigation and hand over the underlying funding agreements at the very start of a federal case. Nothing has been finalized yet, but the direction is unmistakable: disclosure, not prohibition, is where US federal reform is heading.

What Compliance Teams Should Be Tracking Right Now

If your organization faces or brings funded litigation in US federal court, keep an eye on three things simultaneously: the status of S. 3826 in the Senate, whether the Advisory Committee on Civil Rules moves its Rule 26 proposal toward formal publication, and any state-specific licensing requirement in the jurisdiction where your case sits. These three tracks move independently, and a compliance calendar that only watches one of them will miss the others.

The United Kingdom: Self-Regulation Shaken by PACCAR

The PACCAR Problem in Plain Terms

For years, the UK ran on a fairly simple model: litigation funding largely operated through self-regulation and judicial oversight of individual agreements, without dedicated legislation. That changed after the Supreme Court’s PACCAR decision, which reclassified many funding agreements as damages-based agreements, throwing a wrench into how funders structured their returns. The ripple effects have been significant enough that the government has now committed to fixing it directly.

Legislation Now on the Way

In December 2025, the UK government announced it would legislate specifically to address the fallout from PACCAR, with two clear aims: clarifying that funding agreements are not damages-based agreements, with prospective effect, and introducing proportionate regulation of those agreements to improve transparency and fairness for claimants. This follows the Civil Justice Council’s own review of the sector. Until that legislation actually passes, though, the UK framework remains a hybrid: partly judicial, partly self-regulatory, and partly in transition. Anyone drafting or challenging a UK funding agreement right now needs to track this timeline closely, since the ground is genuinely shifting under existing contracts.

The European Union: No EU-Wide Law, at Least for Now

Article 10 of the RAD Is the Only Hard Rule

If you’re asking whether the practice is legal across the EU as a bloc, the honest answer is that there’s remarkably little EU-specific law on the subject. The one binding provision is Article 10 of the Representative Actions Directive, which applies specifically to funded consumer representative actions and requires member states to prevent conflicts of interest and ensure funders don’t influence the action in a way that compromises consumer protection. Outside that narrow context, funding largely runs on ordinary national contract law, civil procedure, and professional ethics rules, which naturally means the practical experience of funding a case varies considerably between, say, Germany and Ireland.

The Mapping Study and a Stalled Directive

The European Parliament called for EU-wide rules back in 2022, prompting the European Commission to commission an extensive mapping study covering all member states plus the UK, US, Canada, and Switzerland. Despite that groundwork, the Commission’s own justice commissioner indicated recently that, following feedback from stakeholders, there is currently no need to regulate third party litigation funding at EU level, with attention instead shifting toward monitoring how the existing Representative Actions Directive gets implemented. That said, pressure hasn’t disappeared. Industry groups have continued pushing for harmonized rules, and Germany and the Netherlands remain the most active funding markets on the continent, so this is very much a live conversation rather than a settled one. AEQUIFIN’s own litigation funding overview reflects how one active German-based marketplace structures its funding agreements within this still-evolving EU landscape.

What This Means Practically for Lawyers and Compliance Teams

A Quick Cross-Jurisdiction Checklist

Before advising a client on any funded matter, confirm whether the relevant state or country requires disclosure of the funding arrangement to the court, whether there’s a licensing or registration requirement for the funder itself, whether any interest-rate or return cap applies to the specific agreement, and whether pending legislation could retroactively affect an agreement already in place. That last point matters more than most people assume, since the PACCAR situation in the UK is a textbook example of a court decision reshaping agreements that were signed under an entirely different assumption.

Conclusion

Is litigation funding legal in the US, UK, and EU? Broadly, yes, in the sense that no major jurisdiction bans the practice outright. But legal doesn’t mean uniformly regulated, and that gap is exactly where the risk sits for lawyers and compliance teams handling cross-border matters. The US is racing toward federal disclosure requirements while individual states keep their own caps and licensing rules. The UK is mid-transition following PACCAR, with new legislation incoming. The EU has, for now, stepped back from a unified directive while individual member states continue operating under their own contract and consumer law. None of this is static, so building a compliance process that revisits each jurisdiction’s status regularly is the only reliable way to stay ahead of it.

Frequently Asked Questions

1. Is litigation funding legal in every US state?

Generally yes, though the specific rules, licensing requirements, and interest rate caps vary considerably from state to state, so a national compliance approach needs state-by-state verification.

2. Does the UK currently require disclosure of third party litigation funding?

Not universally under statute yet, though courts have scrutinized funding arrangements case by case, and the government’s incoming legislation is expected to introduce clearer transparency requirements.

3. Is there an EU-wide law regulating litigation funding?

No. The only binding EU rule is Article 10 of the Representative Actions Directive, which applies narrowly to funded consumer representative actions, not litigation funding generally.

4. Why does the PACCAR decision matter for existing UK funding agreements?

It reclassified many funding agreements as damages-based agreements, which affected their enforceability, prompting the UK government to commit to legislation clarifying the position going forward.

5. What should compliance teams prioritize if they operate across all three jurisdictions?

Track pending federal and state legislation in the US, the UK’s post-PACCAR legislative timeline, and any national-level developments in the EU member states where cases are active, since none of these frameworks are currently static.